198
Participants
Start Date
January 27, 2025
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2030
Doxorubicin
60 mg/m² intravenous (IV) at Day 1 every 3 weeks (4 cycles)
Trabectedin
1.1 mg/m² intravenous (IV) at Day 1 every 3 weeks (4 cycles)
NOT_YET_RECRUITING
Institut Paoli Calmettes, Marseille
RECRUITING
La Timone University Hospital, Marseille
NOT_YET_RECRUITING
Centre Francois Baclesse, Caen
NOT_YET_RECRUITING
Centre Georges Francois Leclerc, Dijon
NOT_YET_RECRUITING
Hopital Jean Minjoz, Besançon
NOT_YET_RECRUITING
Institut Claudius Regaud, Toulouse
NOT_YET_RECRUITING
Institut Bergonie, Bordeaux
NOT_YET_RECRUITING
Centre Eugene Marquis, Rennes
NOT_YET_RECRUITING
CHU Bretonneau, Tours
NOT_YET_RECRUITING
Institut de cancerologie de l'ouest site Rene Gauducheau, Saint-Herblain
NOT_YET_RECRUITING
Institut de Cancerologie de L'Ouest (Ico), Angers
NOT_YET_RECRUITING
Centre Alexis Vautrin, Vandœuvre-lès-Nancy
NOT_YET_RECRUITING
Centre Jean Perrin, Clermont-Ferrand
NOT_YET_RECRUITING
Centre Léon Berard, Lyon
NOT_YET_RECRUITING
Hopital Saint Louis, Paris
NOT_YET_RECRUITING
Hôpital Cochin, Paris
NOT_YET_RECRUITING
Groupe Hospitalier Diaconesses Croix St Simon, Paris
NOT_YET_RECRUITING
Hopital Tenon, Paris
NOT_YET_RECRUITING
Centre Henri Becquerel, Rouen
NOT_YET_RECRUITING
Chu de Poitiers, Poitiers
NOT_YET_RECRUITING
Chu Limoges, Limoges
RECRUITING
Gustave Roussy, Villejuif
NOT_YET_RECRUITING
Centre Antoine Lacassagne, Nice
NOT_YET_RECRUITING
Institut Curie, Paris
NOT_YET_RECRUITING
Institut de Cancerologie Strasbourg Europe (Icans), Strasbourg
Collaborators (3)
PharmaMar
INDUSTRY
Ligue contre le cancer, France
OTHER
National Research Agency, France
OTHER
University Hospital, Marseille
OTHER
Institut Claudius Regaud
OTHER
Institut Bergonié
OTHER
Oncopole
UNKNOWN
UNICANCER
OTHER